A Study of Renal Microvessel Imaging for Chronic Kidney Disease

Renal Microvessel Imaging for Characterization of Chronic Kidney Disease

The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.

Inclusion Criteria:

- Healthy volunteers or Chronic Kidney Disease (CKD) patients with clinically indicated renal biopsy.

Exclusion Criteria:

• Subjects lacking capacity to consent.
• Vulnerable subjects such as prisoners; pregnant women; nursing mother.
• Subjects with history of hypersensitivity allergic reactions to ultrasound contrast agents.
• Patients with high-risk cardiac diseases.